SLShinn-Zong Lin

Shinn-Zong Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shinn-Zong Lin has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Lin et al. Protective Anti-Inflammatory and Antioxidant Mechanisms of Ohwia caudata Leaf Hydroethanolic Extract in a Dermatitis Mouse Model. Life 2025, 15, 1707

    by Tzu-Kai Lin, Bruce Chi-Kang Tsai, Shih-Wen Kao, Chia-Lun Tsai, Chia-Hua Kuo, Tsung-Jung Ho, Dennis Jine-Yuan Hsieh, Shinn-Zong Lin, Wei-Wen Kuo, Chih-Yang Huang

  • Open Access

    Astragalus and Cordyceps Derivatives in the Treatment of Aging-Related Chronic Diseases and Neurodegenerative Disorders

    by Kiran Reddy Kanubaddi, Chih-Liang Yaung, Horng-Jyh Harn, Tzyy-Wen Chiou, Shao-Xi Hsu, Ivan Wijaya, Shinn-Zong Lin, Wei Wuli

    Aging is associated with a rising burden of chronic metabolic, cardiovascular, musculoskeletal, and neurodegenerative diseases that share interconnected pathological mechanisms, including oxidative stress, chronic inflammation, mitochondrial dysfunction, metabolic imbalance, and immune dysregulation. Because these disorders arise from complex and overlapping biological disturbances, conventional single-target therapies often provide only limited benefit. In this context, traditional Chinese herbal medicines, characterized by multi-component and multi-target actions, are being re-evaluated using modern pharmacological and systems biology approaches. Among these, Astragalus membranaceus and Cordyceps species have attracted attention as representative tonic medicines with long-standing traditional use and growing biomedical relevance. Their principal bioactive constituents, including polysaccharides, saponins, flavonoids, sterols, and nucleoside derivatives such as cordycepin, exert pleiotropic effects on inflammatory signaling, redox homeostasis, mitochondrial function, metabolic regulation, and immune responses. This review summarizes current evidence on bioactive derivatives from Astragalus and Cordyceps in aging-related chronic and neurodegenerative disorders, including diabetes, cardiovascular dysfunction, osteoarthritis, cancer, Alzheimer’s disease, and Parkinson’s disease. It focuses on mechanistic findings from cellular and animal studies and critically discusses key translational challenges, such as compositional variability, poor bioavailability, lack of standardized preparation, limited clinical validation, and safety concerns related to toxicity and herb–drug interactions.


  • Open Access

    miR-100-5p Enhances Cell Cycle-Mediated Chemoresistance by Modulating the CTDSPL/pRB/E2F1 Signaling Pathway in Oxaliplatin-Resistant Colorectal Cancer Cells

    by Yen-Pin Chen, Rathinasamy Baskaran, Hema Sri Devi, Chaouhan Hitesh Singh, Yu-Jung Lin, Marthandam Asokan Shibu, Wei-Wen Kuo, Shih-Chieh Liao, Ming-Cheng Chen, Tso-Fu Wang, et al.

    Objective: MicroRNAs (miRNAs) are small, non-coding RNAs that play a key role in the development of chemoresistance in various cancer types, including colorectal cancer (CRC). In this study, we aimed to study the underlying mechanisms of miRNA in chemotherapy-resistant CRC. Methods: LoVo CRC cell line was exposed to oxaliplatin at an increased dose, and cells were cultured in the presence of oxaliplatin to develop LoVoOXR cells. Microarray and Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR), western blot, and transwell assay were used to evaluate the chemoresistance in LoVoOXR CRC cells. Results: Microarray and qRT-PCR analysis showed an increased expression of miR-100-5p in LoVoOXR cells. MTT assay and flow cytometry analysis revealed less apoptosis and higher cell viability in LoVoOXR cells. mRNA prediction target gene analysis showed C-terminal domain small phosphatase-like (CTDSPL), a phosphatase-like tumor suppressor, as a key target of miR-100-5p. CTDSPL expression was low in LoVoOXR cells compared to LoVoWT cells. miR-100-5p regulates G1/S and S-phase transitions and inhibits differentiation by targeting the CTDSPL/pRB/E2F1 signaling pathway, which involves the modulation of cell cycle effectors in LoVoOXR cells. Further, we found that forkhead box P3 (FOXP3), as the upstream target of miR-100-5p, is highly expressed in LoVoOXR cells. Inhibiting miR-100-5p and FOXP3 down-regulates miR-100-5p expression, while increased CTDSPL expression contributed to reduced cell proliferation and promoted cell apoptosis in LoVoOXR CRC cells. Conclusions: miR-100-5p plays an oncogenic role in inducing chemoresistance through modulation of the CTDSPL/retinoblastoma protein (pRB)/E2F transcription factor 1 (E2F1) axis in CRC cells.

  • The role of Mir-365-5p in regulating NF2-Mediated apoptosis and ROS production in hypoxic cardiomyoblasts

    by Chih-Hsueh Lin, Wei-Yun Wang, Bruce Chi-Kang Tsai, Wei-Wen Kuo, Chia-Hua Kuo, Kuan-Ho Lin, Tsung-Jung Ho, Pei-Ying Pai, Dennis Jine-Yuan Hsieh, Chih-Yang Huang, et al.

    Background Prolonged hypoxia is known to induce reactive oxygen species (ROS) accumulation, leading to cellular damage, particularly in cardiac cells. MicroRNAs (miRNAs) have emerged as key regulators in cellular responses to hypoxia. This study investigated the role of miR-365-5p in hypoxia-induced injury in H9c2 cardiomyoblasts and explored the potential protective effects of bioactive compounds derived from the Jing Si herbal tea. Methods and results Microarray analysis was employed to identify differentially expressed miRNAs in H9c2 cells subjected to 24-hour hypoxic conditions. Among several candidates, mir-365-5p was found to be significantly downregulated, correlating with the upregulation of neurofibromin 2 (NF2), a known regulator of apoptotic signaling pathways. Functional studies using a mir-365-5p mimic revealed that NF2 expression was suppressed, ROS accumulation was decreased, and intrinsic apoptosis was attenuated. Similarly, NF2 knockdown via siRNA recapitulated the protective effects of the mir-365-5p mimic under hypoxic conditions. In parallel, high-performance liquid chromatography (HPLC) was utilized to isolate three individual compounds from Jing Si herbal tea. Treatment with these compounds prevented the hypoxia-induced downregulation of mir-365-5p, suggesting a mechanism for their cardioprotective action. Conclusions The mir-365-5p served as a crucial modulator of hypoxia-induced oxidative stress and apoptosis in H9c2 cardiomyoblasts through the regulation of NF2. Compounds derived from Jing Si herbal tea may exert cardioprotective effects by sustaining mir-365-5p expression under hypoxic conditions. These findings highlight the therapeutic potential of targeting the mir-365-5p/NF2 axis in cardiac injury.


  • Open Access

    Protective Anti-Inflammatory and Antioxidant Mechanisms of Ohwia caudata Leaf Hydroethanolic Extract in a Dermatitis Mouse Model

    by Tzu-Kai Lin, Bruce Chi-Kang Tsai, Shih-Wen Kao, Chia-Lun Tsai, Chia-Hua Kuo, Tsung-Jung Ho, Dennis Jine-Yuan Hsieh, Shinn-Zong Lin, Wei-Wen Kuo, Chih-Yang Huang

    Contact dermatitis is a common inflammatory skin disorder characterized by erythematous and pruritic lesions caused by irritant exposure. Ohwia caudata, a traditional medicinal plant, possesses anti-inflammatory and antioxidant properties, but its dermatoprotective potential remains unclear. To investigate the protective effects and mechanisms of Ohwia caudata leaves’ hydroethanolic extract in a murine model of TPA-induced contact dermatitis. Major phytochemicals in Ohwia caudata extract were identified by HPLC–MS. SKH1/J hairless mice were topically treated with Ohwia caudata extract following TPA stimulation. Skin barrier function was assessed by transepidermal water loss and hydration. Inflammatory (IL-6, TNF-α, TGF-β), antioxidant (SIRT1, Nrf2, HO-1), and ERK-related (p-ERK, eIF2α, ATF-4, CHOP) proteins were analyzed by immunoblotting and immunofluorescence. HPLC–MS revealed harmine, swertisin, isoliquiritigenin, eupatilin, 3′,4′-dimethoxyflavone, and nerolidol as key constituents. The extract significantly reduced transepidermal water loss and enhanced hydration, indicating improved barrier integrity. It downregulated IL-6 and TNF-α while restoring TGF-β expression. ERK and downstream eIF2α/ATF-4/CHOP activation were suppressed, whereas SIRT1/Nrf2/HO-1 antioxidant signaling was enhanced. Ohwia caudata leaves hydroethanolic extract protects against TPA-induced dermatitis by improving skin barrier function, suppressing inflammation, and activating antioxidant defense, supporting its potential as a natural therapeutic for inflammatory skin diseases.


  • β-sitosterol suppresses fibroblast growth factor and epidermal growth factor receptors to induce apoptosis and inhibit migration in lung cancer: an in vitro study

    by Shun-An Kan, Musarat Hussain, Chikondi Jassi, Wei-Wen Kuo, Chia-Hua Kuo, Pei-Ying Pai, Shu-Hui Lin, Yueh-Min Lin, Chih-Yang Huang, Shinn-Zong Lin

    β-Sitosterol (BS), is a significant bioactive component of phytosterols found in plants, foods, and dietary supplements. Its nutritional benefits include lowering of cholesterol levels, boost immune system as well as reduce inflammation. Previous studies have demonstrated its significant anticancer effects across various human cancers. However, the specific mechanisms of action of BS in lung cancer remain unclear. This study aimed to investigate the mechanisms through which BS exerts its anticancer properties in human lung cancer cells, focusing on its anti-proliferative, apoptotic, cytotoxic, and anti-migratory effects. We conducted an in vitro study to assess the effects of BS on lung cancer cell lines A549 and H1975. We used a range of assays, including MTT, western blot, wound healing, transwell migration, immunofluorescence, TUNEL, and cell survival assays, to evaluate the impact of BS on cell proliferation, apoptosis, cytotoxicity, and migration. Our findings indicate that BS inhibits the proliferation of lung cancer cells in a time- and dose-dependent manner. It significantly promotes apoptosis and impairs both cancer cell migration and survival. Additionally, BS suppresses the expression of both fibroblast growth factor receptor-1 (FGFR1) and epidermal growth factor (EGFR), leading to the downregulation of the PI3K/AKT/mTOR/CD1 signaling pathway. BS demonstrates significant anticancer potential in lung cancer cells by inhibiting proliferation, inducing apoptosis, and reducing cell migration. These effects are likely mediated by the concurrent downregulation of FGFR1 and EGFR, leading to the inhibition of the PI3K/AKT/mTOR/CD1 signaling pathway, thereby warranting further investigation of BS as a potential therapeutic agent for lung cancer.


  • Open Access

    Deep Residual Learning-Based Classification with Identification of Incorrect Predictions and Quantification of Cellularity and Nuclear Morphological Features in Digital Pathological Images of Common Astrocytic Tumors

    by Yen-Chang Chen, Shinn-Zong Lin, Jia-Ru Wu, Wei-Hsiang Yu, Horng-Jyh Harn, Wen-Chiuan Tsai, Ching-Ann Liu, Ken-Leiang Kuo, Chao-Yuan Yeh, Sheng-Tzung Tsai

    Interobserver variations in the pathology of common astrocytic tumors impact diagnosis and subsequent treatment decisions. This study leveraged a residual neural network-50 (ResNet-50) in digital pathological images of diffuse astrocytoma, anaplastic astrocytoma, and glioblastoma to recognize characteristic pathological features and perform classification at the patch and case levels with identification of incorrect predictions. In addition, cellularity and nuclear morphological features, including axis ratio, circularity, entropy, area, irregularity, and perimeter, were quantified via a hybrid task cascade (HTC) framework and compared between different characteristic pathological features with importance weighting. A total of 95 cases, including 15 cases of diffuse astrocytoma, 11 cases of anaplastic astrocytoma, and 69 cases of glioblastoma, were collected in Taiwan Hualien Tzu Chi Hospital from January 2000 to December 2021. The results revealed that an optimized ResNet-50 model could recognize characteristic pathological features at the patch level and assist in diagnosis at the case level with accuracies of 0.916 and 0.846, respectively. Incorrect predictions were mainly due to indistinguishable morphologic overlap between anaplastic astrocytoma and glioblastoma tumor cell area, zones of scant vascular lumen with compact endothelial cells in the glioblastoma microvascular proliferation area mimicking the glioblastoma tumor cell area, and certain regions in diffuse astrocytoma with too low cellularity being misrecognized as the glioblastoma necrosis area. Significant differences were observed in cellularity and each nuclear morphological feature among different characteristic pathological features. Furthermore, using the extreme gradient boosting (XGBoost) algorithm, we found that entropy was the most important feature for classification, followed by cellularity, area, circularity, axis ratio, perimeter, and irregularity. Identifying incorrect predictions provided valuable feedback to machine learning design to further enhance accuracy and reduce errors in classification. Moreover, quantifying cellularity and nuclear morphological features with importance weighting provided the basis for developing an innovative scoring system to achieve objective classification and precision diagnosis among common astrocytic tumors.


  • Open Access

    Isolation, Identification, and Characterization of Bioactive Peptides in Human Bone Cells from Tortoiseshell and Deer Antler Gelatin

    by Tsung-Jung Ho, Jung-Hsing Lin, Shinn Zong Lin, Wan-Ting Tsai, Jia-Ru Wu, Hao-Ping Chen

    Tortoiseshell and deer antler gelatin has been used to treat bone diseases in Chinese society. A pepsin-digested gelatin peptide with osteoblast-proliferation-stimulating properties was identified via LC-MS/MS. The resulting pentapeptide, TSKYR, was presumably subjected to further degradation into TSKY, TSK, and YR fragments in the small intestine. The above four peptides were chemically synthesized. Treatment of tripeptide TSK can lead to a significant 30- and 50-fold increase in the mineralized nodule area and density in osteoblast cells and a 47.5% increase in the number of chondrocyte cells. The calcium content in tortoiseshell was relatively higher than in human soft tissue. The synergistic effects of calcium ions and the peptides were observed for changes in osteoblast proliferation and differentiation. Moreover, these peptides can enhance the expression of RUNX2, OCN, FGFR2, and FRFR3 genes in osteoblasts, and aggrecan and collagen type II in chondrocyte (patent pending).


  • Open Access

    Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance

    by Ching-Ann Liu, Wei-Hsiu Liu, Hsin-I Ma, Yuan-Hao Chen, Dueng-Yuan Hueng, Wen-Chiuan Tsai, Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou, Jen-Wei Liu, et al.

    In recurrent glioblastoma, Gliadel wafer implantation after surgery has been shown to result in incomplete chemical removal of residual tumor and development of brain edema. Furthermore, temozolomide (TMZ) resistance caused by O6-methylguanine-DNA-methyltransferase (MGMT) activation and programmed cell death-ligand 1 (PD-L1) expression leads to immune-cold lesions that result in poorer prognosis. Cerebraca wafer, a biodegradable polymer containing (Z)-n-butylidenephthalide (BP), is designed to eliminate residual tumor after glioma resection. An open-label, one-arm study with four dose cohorts, involving a traditional 3 + 3 dose escalation clinical trial, of the Cerebraca wafer combined with TMZ on patients with recurrent high-grade glioma, was conducted. Of the 12 patients who receive implantation of Cerebraca wafer, there were no drug-related adverse events (AEs) or serious AEs (SAEs). The median overall survival (OS) of patients receiving low-dose Cerebraca wafer was 12 months in the group with >25% wafer coverage of the resected tumor, which is longer than OS duration in previously published studies (Gliadel wafer, 6.4 months). Patients who received high-dose Cerebraca wafer treatment had not yet died at the data cut-off date; a 100% progression-free survival (PFS) rate at six month was achieved, indicating the median OS of cohort IV was more than 17.4 months. In vitro study of the primary cells collected from the patients revealed that the IC50 of BP against tumor stem cells was four times lower than that of bis-chloroethylnitrosourea (BCNU). A synergistic effect between BP and TMZ was demonstrated by a reduction in MGMT expression. Furthermore, BP inhibited PD-L1 expression, thereby activating T-cell cytotoxicity and increasing interferon-gamma (IFN-γ) secretion. The better therapeutic effect of Cerebraca wafer on recurrent high-grade glioma could occur through re-sensitization of TMZ and reduction of PD-L1.


  • Open Access

    3-N-butylphthalide protects against high-fat-diet-induced obesity in C57BL/6 mice and increases metabolism in lipid-accumulating cells

    by Kang-Yun Lu, Shinn-Zong Lin, Kingsley Theras Primus Dass, Wei-Ju Lin, Shih-Ping Liu, Horng-Jyh Harn